Kong Nathan W, Upadhyay Gaurav A
Department of Internal Medicine, University of Chicago Medicine, Chicago, IL, United States.
Section of Cardiology, Center for Arrhythmia Care, University of Chicago Medicine, Chicago, IL, United States.
Front Physiol. 2022 Sep 15;13:962042. doi: 10.3389/fphys.2022.962042. eCollection 2022.
Cardiac resynchronization therapy (CRT) via biventricular pacing (BiVP) is an established treatment for patients with left ventricular systolic heart failure and intraventricular conduction delay resulting in wide QRS. Seminal trials demonstrating mortality benefit from CRT were conducted in patients with wide left bundle branch block (LBBB) pattern on electrocardiogram (ECG) and evidence of clinical heart failure. The presence of conduction block was assumed to correlate with commonly applied criteria for LBBB. More recent data has challenged this assertion, revealing that LBBB pattern may include distinct underlying pathophysiology, including patients with complete conduction block, either at the left-sided His fibers or the proximal left bundle, intact Purkinje activation with wide LBBB-like QRS, and patients demonstrating both proximal block and distal delay. Currently, BiVP-CRT is indicated for all QRS duration ≥150 ms and may be considered for BBB patterns from 130 to 149 ms with robust clinical data to support its use. Despite this, however, there remains a significant number of non-responders to BVP. Conduction system pacing (CSP) has emerged as an alternative approach to deliver CRT and correct QRS in patients with conduction block. Newer hybrid approaches which combine CSP and traditional BiVP-CRT and may hold promise for patients with IP or mixed-level block. As various approaches to CRT continue to be studied, physiologic phenotyping of the LBBB pattern remains an important consideration.
通过双心室起搏(BiVP)进行心脏再同步治疗(CRT)是治疗左心室收缩性心力衰竭且存在室内传导延迟导致QRS波增宽患者的既定疗法。一些开创性试验表明,心电图(ECG)呈宽左束支传导阻滞(LBBB)图形且有临床心力衰竭证据的患者可从CRT中获益。当时认为传导阻滞的存在与常用的LBBB标准相关。但最近的数据对这一观点提出了挑战,表明LBBB图形可能包含不同的潜在病理生理学机制,包括左侧希氏纤维或左束支近端完全传导阻滞的患者、浦肯野纤维激活完整但QRS波呈宽LBBB样的患者,以及同时存在近端阻滞和远端延迟的患者。目前,BiVP-CRT适用于所有QRS波时限≥150毫秒的患者,对于QRS波时限在130至149毫秒的束支传导阻滞(BBB)图形患者,若有有力的临床数据支持其使用,也可考虑采用。尽管如此,仍有相当数量的患者对BVP无反应。传导系统起搏(CSP)已成为在传导阻滞患者中实施CRT并纠正QRS波的一种替代方法。将CSP与传统BiVP-CRT相结合的新型混合方法可能对存在室内阻滞(IP)或混合水平阻滞的患者有前景。随着对CRT各种方法的持续研究,LBBB图形的生理表型分析仍是一个重要的考虑因素。